- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Cathelicidin LL-37 in Cancer Development
Authors
Keywords
Cancer, Immune system, Carcinogenesis, Cathelicidin, LL-37
Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 64, Issue 1, Pages 33-46
Publisher
Springer Nature
Online
2015-09-23
DOI
10.1007/s00005-015-0359-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polymorphism of the IL-8 gene and the risk of ovarian cancer
- (2015) D. Koensgen et al. CYTOKINE
- Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
- (2015) Katarzyna Niemirowicz et al. International Journal of Nanomedicine
- A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line
- (2015) Azmi Yerlikaya et al. Journal of Proteomics
- Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer
- (2015) Adam D. Steg et al. Oncotarget
- Association Between Interleukin-8 –251A/T Polymorphism and Risk of Lung Cancer: A Meta-Analysis
- (2014) Ping Gao et al. CANCER INVESTIGATION
- Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation
- (2014) Ka-Yee G. Choi et al. IMMUNOLOGY
- Tuberculosis and risk of cancer: a Danish nationwide cohort study
- (2014) D. F. Simonsen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Caspase 3 Promotes Surviving Melanoma Tumor Cell Growth after Cytotoxic Therapy
- (2014) Anne L. Donato et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Role of mesenchymal cells in the natural history of ovarian cancer: a review
- (2014) Cyril Touboul et al. Journal of Translational Medicine
- Efficient apoptosis and necrosis induction by proteasome inhibitor: bortezomib in the DLD-1 human colon cancer cell line
- (2014) Rafał Krętowski et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis
- (2014) N Prevete et al. ONCOGENE
- Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides
- (2014) Sibel Dosler et al. PEPTIDES
- Elevated Interleukin-32 Expression Is Associated with Helicobacter pylori-Related Gastritis
- (2014) Liu-sheng Peng et al. PLoS One
- Toll-Like Receptor 4 Signaling Promotes the Migration of Human Melanoma Cells
- (2014) Yuko Takazawa et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Effect ofHelicobacter pylorion gastric epithelial cells
- (2014) Shatha Alzahrani WORLD JOURNAL OF GASTROENTEROLOGY
- Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
- (2014) Maria Muccioli et al. Frontiers in Immunology
- Ceragenin CSA-13 induces cell cycle arrest and antiproliferative effects in wild-type and p53 null mutant HCT116 colon cancer cells
- (2013) Kengo Kuroda et al. ANTI-CANCER DRUGS
- Mitogen-Activated Protein Kinase Phosphatase 1 as an Inflammatory Factor and Drug Target
- (2013) Riku Korhonen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression
- (2013) Qingli Zeng et al. CYTOKINE
- IL-32 Promotes Angiogenesis
- (2013) C. A. Nold-Petry et al. JOURNAL OF IMMUNOLOGY
- IL-32 expression is an independent prognostic marker for gastric cancer
- (2013) Sumiya Ishigami et al. MEDICAL ONCOLOGY
- Human cathelicidin peptide LL37 binds telomeric G-quadruplex
- (2013) Jagannath Jana et al. Molecular BioSystems
- FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells
- (2013) Shun X. Ren et al. PLoS One
- The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
- (2013) Silke M. Currie et al. PLoS One
- Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation
- (2013) M Castells et al. Cell Death & Disease
- Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer
- (2013) Ratana Lim et al. Journal of Ovarian Research
- Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
- (2012) S. X. Ren et al. CANCER RESEARCH
- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- A comprehensive summary of LL-37, the factotum human cathelicidin peptide
- (2012) Dieter Vandamme et al. CELLULAR IMMUNOLOGY
- Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis
- (2012) Jayshree Mishra et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer
- (2012) Nasser Ghaly Yousif et al. CYTOKINE
- Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
- (2012) Ignacio Romero et al. ENDOCRINOLOGY
- Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites
- (2012) Rosa Rico-Mata et al. EXPERIMENTAL PARASITOLOGY
- Role of Interleukin-32 in Helicobacter pylori-Induced Gastric Inflammation
- (2012) Kosuke Sakitani et al. INFECTION AND IMMUNITY
- Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections
- (2012) K. Leszczynska et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
- (2011) T. V. Clendenen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene
- (2011) Sojung Lee et al. IMMUNOLOGY
- Cathelicidin LL-37 Increases Lung Epithelial Cell Stiffness, Decreases Transepithelial Permeability, and Prevents Epithelial Invasion by Pseudomonas aeruginosa
- (2011) F. J. Byfield et al. JOURNAL OF IMMUNOLOGY
- Involvement of P2X7 purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts
- (2011) P. Montreekachon et al. JOURNAL OF PERIODONTAL RESEARCH
- Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
- (2011) Qian Huang et al. NATURE MEDICINE
- The autophagic paradox in cancer therapy
- (2011) W K K Wu et al. ONCOGENE
- Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor
- (2011) A Girnita et al. ONCOGENE
- Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
- (2011) Peter G. Barlow et al. PLoS One
- Cathelicidin LL-37: A Multitask Antimicrobial Peptide
- (2010) Robert Bucki et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma
- (2010) J.E. Kim et al. BRITISH JOURNAL OF DERMATOLOGY
- Proteasome inhibition: A new therapeutic strategy to cancer treatment
- (2010) William Ka Kei Wu et al. CANCER LETTERS
- Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications
- (2010) William K.K. Wu et al. INTERNATIONAL JOURNAL OF CANCER
- LL-37 as a therapeutic target for late stage prostate cancer
- (2010) Jonathan A. Hensel et al. PROSTATE
- Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype
- (2009) Carlo Sorrentino et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting the telosome: Therapeutic implications
- (2009) Marco Folini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Human telomeric G-quadruplex: The current status of telomeric G-quadruplexes as therapeutic targets in human cancer
- (2009) Stephen Neidle FEBS Journal
- Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer
- (2009) Chi-Mu Chuang et al. HUMAN GENE THERAPY
- LL-37 Promotes Rapid Sensing of CpG Oligodeoxynucleotides by B Lymphocytes and Plasmacytoid Dendritic Cells
- (2009) P. Hurtado et al. JOURNAL OF IMMUNOLOGY
- The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity
- (2009) J. S. Mader et al. MOLECULAR CANCER RESEARCH
- The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
- (2009) S. B. Coffelt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- No death without life: vital functions of apoptotic effectors
- (2008) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
- Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
- (2008) J. Overhage et al. INFECTION AND IMMUNITY
- Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13
- (2008) R. Bucki et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- p53: The Janus of autophagy?
- (2008) Beth Levine et al. NATURE CELL BIOLOGY
- Cancer is a Preventable Disease that Requires Major Lifestyle Changes
- (2008) Preetha Anand et al. PHARMACEUTICAL RESEARCH
- The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells
- (2007) Judith von Haussen et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started